Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
MNPR
#3118
Monopar Therapeutics Inc. Common Stock
57.920
0
USD
+3.28%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+3.28%
Aylık Değişim
-4.06%
6 aylık değişim
+6.04%
Yıllık Değişim
+6.04%
Önceki Kapanış
56.080
0
Open
57.920
0
Bid
Ask
Low
57.920
0
High
57.920
0
Hacim
15
Piyasalar
ABD Borsası
Sağlık Hizmetleri
MNPR
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.51 M
2.52 M
2.64 M
3.49 M
6.11 M
6.69 M
—
Valuation ratios
Enterprise value
60.17 M
20.16 M
22.42 M
-807.76 K
88.66 M
375.16 M
1.16 B
Price to earnings ratio
—
—
-2.81
-0.61
-5.35
-35.28
-73.07
Price to sales ratio
—
—
1 389.24
11.92
—
—
—
Price to cash flow ratio
—
—
-4.08
-0.65
-13.02
-39.66
-122.49
Price to book ratio
—
—
2.92
0.92
1.52
3.51
7.75
Enterprise value to EBITDA ratio
—
—
—
—
—
-21.54
—
Profitability ratios
Return on assets %
-0.37
-0.44
-0.8
-1.14
-0.26
-0.1
-0.15
Return on equity %
-0.4
-0.48
-1.04
-1.5
-0.28
-0.1
-0.16
Return on invested capital %
-27.31 K
-42.46 K
-51.3 K
-95.64 K
-1.02 M
-875.03
-318.39 K
Gross margin %
100
100
-291.89
100
—
—
—
Operating margin %
-7 947.15
-37.99 K
-49.61 K
-2 058.38
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-7 697.7
-37.89 K
-49.51 K
-1 958.38
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
14.28
12.19
4.21
4.17
26.74
51.35
178.31
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0
0
0.04
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.84
-2.84
-1.69
-1.65
-1.71
EBIT per share
—
—
-4.17
-3.04
-4.26
-2.25
—
EBITDA per share
—
—
—
—
—
-2.35
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.79
5
24.1
16.56
74.98
Net current asset value per share
—
—
5.18
2.65
15.91
18.95
54.74
Tangible book value per share
—
—
3.97
2.02
14.52
18.6
53.6
Working capital per share
—
—
3.95
2.02
15.31
18.58
53.57
Book value per share
—
—
3.97
2.02
14.52
18.6
53.6
Haberler
BTIG, Monopar Therapeutics için 104 dolarlık hedefi korudu
Leerink, Wilson hastalığı ilacı potansiyeli nedeniyle Monopar hisse notunu korudu
Raymond James, NDA zamanlaması değişikliğine rağmen Monopar hisse notunu korudu
Monopar, Susan Rodriguez’i ticari işler direktörü olarak atadı
Monopar names Susan Rodriguez as chief commercial officer
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Cantor Fitzgerald, Monopar Therapeutics için Overweight notunu yineledi
Monopar Therapeutics stock rating reiterated by Cantor Fitzgerald
BTIG reiterates Buy rating on Monopar Therapeutics stock ahead of NDA submission
Morgan Stanley initiates Monopar Therapeutics stock with Overweight rating
Raymond James, FDA toplantı belirsizliği ortasında Monopar hissesi için Outperform notunu yineliyor
Raymond James reiterates Outperform rating on Monopar stock amid FDA meeting uncertainty